Tag: Neuromodulation

The first wireless spinal cord stimulator system elicits a high response...

A study evaluating different waveforms within a wireless spinal cord stimulator (SCS) device (Stimwave) has found high response rates for patients receiving both high...

Placebo-controlled RCTs of spinal cord stimulation are on the rise, but...

Important methodological aspects of clinical trials of spinal cord stimulation (SCS) using a placebo are consistently being poorly reported, says a recent systematic review....

Stimwave announces completion of enrolment for the Tsunami placebo-controlled double-blind randomised...

Stimwave has announced completion of patient enrolment and preliminary results of the first-of-its-kind Tsunami study. The Tsunami placebo-controlled double-blind randomised clinical trial (RCT) is...
DBS neurosurgical robot

The “neurosurgical robot” facilitates further research in deep brain stimulation

The application of robot-assisted lead implantation in nonhuman primate neuromodulation research has been deemed feasible, accurate, safe and efficient in a recent study published...

NIH study to utilise NeuroPace RNS system for research on the...

NeuroPace has announced that the company’s RNS  system, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy, will be...
neurolief

The first non-invasive, adaptive neuromodulation digital treatment for migraine receives CE...

Neurolief, a developer of digital therapeutics brain neuromodulation technology, has announced that it has received the CE mark for its Relivion non-invasive, adaptive digital treatment...

Latest FDA caution for the use of off-label drugs in intrathecal...

While the US Food and Drug Administration (FDA) has called for caution regarding the use of off-label medications administered intrathecally, pain management experts have...
BrainsWay OCD

New published data affirms BrainsWay’s deep TMS system for the treatment...

BrainsWay has announced new data from an article published in the lastest issue of the American Journal of Psychiatry demonstrating that its deep TMS (dTMS) system...

Cybersecurity: Providers and patients beware

Within the context of evolving technologies that continue to expand healthcare connectivity, Padma Gulur warns of the “immense vulnerability of current systems”. Arguing that...
flow depression

Medication-free treatment for depression launches in the UK

Flow launches a medication-free treatment for depression comprising a brain stimulation headset and therapy app. In Europe, Flow is classified as a Class IIa...

Burst stimulation of the spinal cord leads to greater pain modulation...

Data from a substudy of SUNBURST suggest that burst stimulation of the spinal cord regulates the medial pain pathway to a greater extent than...

“A failure in SCS is not a failure of the therapy...

Defining true success as “being able to decrease or even eliminate a patient’s dependency on oral opioids”, Corey W Hunter, founder of Ainsworth Institute...

Review shows inaccuracies of deep brain stimulation data for minimally conscious...

Results from a systematic review reveal that evidence for the use of deep brain stimulation (DBS) of various targets to promote recovery in patients...

International Neuromodulation Society announces 14th World Congress

The International Neuromodulation Society (INS) will hold its 14th World Congress from May 25–30, 2019 in Sydney, Australia. The multidisciplinary meeting highlights top international...

Study of SPR Therapeutics’ peripheral nerve stimulation system demonstrates sustained relief...

SPR Therapeutics have announced the study results of its SPRINT peripheral nerve stimulation (PNS) system in the treatment of post-amputation pain. The study demonstrated that...

Welkin Health announces partnership to implement a programme to support commercialisation...

Welkin Health, a privately-held patient relationship management software company has announced that it is partnering with Axonics, a company focused on the design, development,...

New data show the therapeutic benefits of directional leads for use...

The PROGRESS study has achieved its primary endpoint and demonstrated superiority of the therapeutic window using Abbott directional stimulation compared to omnidirectional stimulation. Results...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Evoke: The first RCT to measure spinal cord activations in response...

The protocol design for a multicentre, prospective, randomised, double-blind study comparing ECAP- (evoked compound action potential) controlled closed-looped with open-loop, fixed output spinal cord...

Positive results for the treatment of medication-resistant epilepsy using Neuroelectrics’ Starstim

At the recent American Epilepsy Society Annual Meeting in New Orleans, USA, Neuroelectrics presented positive results from its clinical trial treating patients with drug...

Axonics granted full-body MR-conditional CE mark for its sacral neuromodulation system

Axonics has announced that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging conditional labelling for the Axonics r-SNM...

Axonics announce positive clinical data from its ARTISAN sacral neuromodulation pivotal...

Axonics has disclosed positive top-line results from the ARTISAN-SNM pivotal study, designed to gain marketing approval from the US Food and Drug Administration (FDA)...

The future of neurostimulation: Smart neuromodulation

Better understanding of the brain alongside the integration of artificial intelligence may represent the future of neuromodulation. From machine learning and novel technology to...

Majority of radiculopathy patients prefer burst to conventional tonic stimulation

BurstDR stimulation confers a greater reduction in leg and back pain intensity on patients with failed back surgery syndrome that tonic stimulation does, a...

The top 10 takeaways from “The Neuromodulation Appropriateness Consensus Committee on...

In 2018, the International Neuromodulation Society (INS) project on Consensus Conferences published “The Neuromodulation Appropriateness Consensus Committee on Best Practices for Dorsal Root Ganglion...

Companies partner for a non-invasive neuromodulation device to treat spasticity

WeHealth by Servier, the e-health department of Servier Group, and PathMaker Neurosystems, have announced the closing of a partnership agreement to develop and commercialise...

Nuvectra receives full-body MR-conditional CE Mark approval for Algovita

Nuvectra has announced that it has received full-body MR-conditional approval for the Company’s Algovita spinal cord stimulation (SCS) system from its European Notified Body,...

Good news for gamblers: Transcranial direct current stimulation found to enhance...

Transcranial direct current stimulation (tDCS) offers a novel intervention for individuals with gambling disorder, concluded a recent study that found that its use enhanced...

Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...

Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...

SPR Therapeutics awarded US$10M to develop its SPRINT peripheral nerve stimulation...

SPR Therapeutics has been awarded two new grants and one new contract from the US Department of Defense totalling US$10M to further develop its...

SPR Therapeutics announces first use of SPRINT extensa dual-lead peripheral nerve...

SPR Therapeutics, a developer of neurostimulation technology for pain management, has announced that Christopher Gilmore of Carolinas Pain Institute was the first to use...

PathMaker Neurosystems launches European clinical trial of MyoRegulator

PathMaker Neurosystems has announced that it has initiated and successfully enrolled the first patient in its European clinical trial to evaluate MyoRegulator for the non-invasive treatment...

Intellis is now licensed in Canada

Medtronic has announced in a press release that it has received a licence from Health Canada for its Intellis platform, which includes the world's...

Algovita SCS System implantations reach 2,000 in the USA

Nuvectra Corporation, a neurostimulation medical device company, has announced that the Company’s Algovita Spinal Cord Stimulation (SCS) system has been implanted in over 2,000...

Study lays foundation for treating drug, alcohol addicts with noninvasive brain...

In a study investigating the use of transcranial magnetic stimulation (TMS) for drug addiction, researchers at Medical University of South Carolina are the first...

Axonics secures US$40M financing to commercialise neuromodulation device

Axonics has secured US$40 million to support commercialisation of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the...

Soin Neuroscience commences a clinical case series with Nuvectra’s Algovita spinal...

Soin Neuroscience, a biotech company based in Dayton, Ohio, USA, has received IRB (institutional review board) approval to commence a clinical case series to study...

Neurostimulation can be part of the solution to the opioid crisis

The president of the United States of America has recently declared the opioid crisis in that country a “public health emergency”. In light of...

“Shuffle” stimulation improves pain scores in pilot study

A pilot study published in Neuromodulation: Technology at the Neural Interface suggests that high frequency stimulation (HFS), an alternative SCS waveform could also be...

Innovation. Outcomes. Focus on Function.

Medtronic has a long-standing commitment to delivering innovative pain stimulation technology and building the evidence that matters today and leads us into the future. This is again...

NANS responds to California DWC order to discontinue coverage of non-opioid...

The North American Neuromodulation Society (NANS) has issued a response to the California Division of Workers’ Compensation (DWC) order which adopts regulations to update the evidence-based...

Flexible battery could revolutionise implanted devices

Experts at Queen’s University Belfast, Belfast, UK, have designed a flexible battery that could provide an alternative to the rigid batteries that usually power...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Marking 50 years of spinal cord stimulation

The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

CE mark for Vercise Gevia deep brain stimulation system

CE mark has been granted for the Vercise Gevia deep brain stimulation (DBS) system (Boston Scientific), a rechargeable, magnetic resonance (MR) conditional device indicated...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

SureTune3 deep brain stimulation software receives Health Canada licence

Medtronic has received a Health Canada licence for SureTune3 software for deep brain stimulation (DBS). The latest innovations in the SureTune technology are designed...

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...

Giancarlo Barolat

Over a 38-year career, Giancarlo Barolat has performed over 8000 neurostimulation procedures and has seen the field develop and change in a number of...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

How do you design unbiased neuromodulation trials?

At the annual meeting of the Neuromodulation Society of the UK and Ireland (NSUKI; 3–4 November, Manchester, USA) Alan Batterham (Health & Social Care...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

More research needed to show potential of neuromodulation

While much has been done in the past decade to advance the field of neuromodulation, some investigators believe only small steps have been made...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

New guidance on neuromodulation therapy to be published

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centred...

FDA approves BurstDR stimulation for patients with chronic pain

The US Food and Drug Administration (FDA) has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) clinically proven to provide superior outcomes for...

Study finds deep brain stimulation a cost-effective treatment method for Parkinson’s...

It has been established that deep brain stimulation is clinically superior to medical therapy for treating advanced Parkinson’s disease. Jan B Pietzsch (Department of...

Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...

Medtronic has announced US Food and Drug Administration (FDA) clearance of StealthStation cranial software as an aid for deep brain stimulation (DBS) lead placement....

ReActiv8-A sustains performance at one year in clinical trial

Mainstay Medical International has announced the one-year results from the ReActiv8-A Clinical Trial, an international, multi-centre, prospective, single arm trial for ReActiv8 in people...

Study urges earlier consideration of spinal cord stimulation in chronic pain...

A study recently published in the journal Neuromodulation suggests that earlier consideration of spinal cord stimulation in chronic pain care continuum could have a...

SCS TechTalk: Innovation Starts Here

In this Boston Scientific Educational Supplement, you will read about the pace of innovation—from delivering the first and only rechargeable spinal cord stimulation (SCS) system powered by intuitive...

Most patients with chronic trunk or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...

Boston Scientific acquires Cosman Medical radiofrequency ablation manufacturer

Boston Scientific Corporation has acquired Cosman Medical a privately-held manufacturer of radiofrequency ablation systems. According to a press release, the Cosman Medical team and...

Cefaly releases revamped pocket-sized model of migraine headband

Cefaly has announced that its eponymous Cefaly device—which is a US Food and Drug Administration (FDA)-approved external trigeminal nerve stimulation device for the prevention...

Higher spinal cord stimulation frequency may reduce epileptic seizure

The ability of spinal cord stimulation to affect spike-and-wave discharges has been suggested as a means to mitigate epileptic seizures in recent literature. In...

Blue Cross Blue Shield denies coverage for high-frequency spinal cord stimulation...

Blue Cross Blue Shield has denied coverage for high frequency spinal cord stimulation in at least two states. Outposts of the federation of...

St Jude Medical launches Infinity deep brain stimulation system and directional...

St Jude Medical has launched the Infinity deep brain stimulation (DBS) system and directional DBS lead in Europe. The system, which received CE mark approval...

CE mark granted to Mainstay Medical for ReActiv8

Mainstay Medical International has received CE mark approval for ReActiv8, its proprietary implantable neurostimulation system designed to treat disabling chronic low back pain. According to...

Boston Scientific receives US FDA approval for Precision Montage MRI spinal...

  Boston Scientific Corporation has launched the Precision Montage MRI spinal cord stimulator system after receiving approval from the US Food and Drug Administration (FDA)....

First US commercial implants of Axium DRG system announced

St Jude Medical has announced the US launch and first post-approval implants of the St Jude Medical Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation...

Medtronic offer first complete portfolio of full-body MR conditional neurostimulation systems

The US Food and Drug Administration (FDA) has approved Medtronic’s Specify SureScan MRI surgical leads, which are indicated for use as part of Medtronic...

St. Jude Medical: Returning innovation to chronic pain treatment

With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options...

High-density stimulation restores efficacy in failed spinal cord stimulation therapy

By reprogramming existing spinal cord stimulation systems, investigators have been able to restore efficacy in patients who have failed spinal cord stimulation therapy, and...

Timothy Deer

Timothy Deer (Centre for Pain Relief, Charleston, USA) has recently been appointed president of the International Neuromodulation Society. He believes neuromodulation is now the...

Medtronic and Samsung to collaborate on telehealth solutions for neuromodulation patients

Medtronic and Samsung Electronics America are to begin a broad-based strategic alliance aiming to speed up the development of digital health solutions for those...

SUNBURST data demonstrates superior pain relief results for Burst Stimulation over...

St Jude Medical’s Burst stimulation can relieve chronic pain more effectively than traditional tonic spinal cord stimulation (SCS), according to the SUNBURST study. The...

LUMINA data demonstrate 70% greater low back pain relief with Precision...

Final results evaluating the Precision Spectra spinal cord stimulator system (Boston Scientific) demonstrate that the device provides more than 70% greater low back pain...

St Jude Medical launches spinal cord stimulation system in Europe

St Jude Medical has launched its Proclaim Elite spinal cord stimulation (SCS) system in Europe. According to a press release, this is the world’s...

FDA approves Proclaim Elite SCS System

St Jude Medical has announced FDA approval of the new Proclaim Elite Spinal Cord Stimulation System, the first and only upgradeable and recharge-free spinal cord stimulation (SCS)...

Medtronic TYRX Neuro Absorbable Antibacterial Envelope now available for use with...

Medtronic plc has announced the first implants of the TYRX Absorbable Antibacterial Envelope with Medtronic deep brain stimulation (DBS) systems. The implants were conducted...

St Jude Medical receives CE mark for MRI conditional labelling of...

St Jude Medical has received CE mark approval for magnetic resonance imaging (MRI) conditional labelling for the company’s Prodigy MRI chronic pain system with...

FDA clears St Jude Medical Invisible Trial System

St Jude Medical has received Food and Drug Administration (FDA) approval of the Invisible Trial System. The system, which received CE mark in June...

Alim Louis Benabid

Winner of the 2015 Breakthrough Prize in Life Science, the 2014 Lasker DeBakey Clinical Medical Research Award and the North American Neuromodulation Society (NANS)...

St Jude Medical completes acquisition of Spinal Modulation

Now complete, the acquisition of Spinal Modulation adds DRG stimulation technology to the St Jude Medical chronic pain portfolio.

Medtronic announces European approval of the first and only full-body MR...

The expanded approval for full-body MRI scans applies to all patients receiving a new system and to an estimated 13,000 people in Europe already receiving Medtronic DBS therapy.

St Jude Medical announces intent to acquire Spinal Modulation

Following the completion of this acquisition, St Jude Medical will become the only medical device manufacturer to offer radiofrequency ablation (RFA), spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation therapy solutions for the treatment of chronic pain.